WO2005005398A3 - Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof - Google Patents

Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof Download PDF

Info

Publication number
WO2005005398A3
WO2005005398A3 PCT/US2004/020734 US2004020734W WO2005005398A3 WO 2005005398 A3 WO2005005398 A3 WO 2005005398A3 US 2004020734 W US2004020734 W US 2004020734W WO 2005005398 A3 WO2005005398 A3 WO 2005005398A3
Authority
WO
WIPO (PCT)
Prior art keywords
derivatives
group substituted
cyclopropyl group
substituted oxazolidinone
species
Prior art date
Application number
PCT/US2004/020734
Other languages
French (fr)
Other versions
WO2005005398A2 (en
Inventor
Yasumichi Fukuda
Original Assignee
Merck & Co Inc
Kyorin Seiyaku Kk
Yasumichi Fukuda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NZ544237A priority Critical patent/NZ544237A/en
Priority to AT04777196T priority patent/ATE471937T1/en
Priority to DE602004027811T priority patent/DE602004027811D1/en
Priority to CN200480019102.2A priority patent/CN1816548B/en
Application filed by Merck & Co Inc, Kyorin Seiyaku Kk, Yasumichi Fukuda filed Critical Merck & Co Inc
Priority to EP04777196A priority patent/EP1646629B1/en
Priority to CA2530140A priority patent/CA2530140C/en
Priority to BRPI0411688-7A priority patent/BRPI0411688A/en
Priority to AU2004256083A priority patent/AU2004256083B2/en
Priority to JP2006517736A priority patent/JP4607107B2/en
Priority to MXPA06000228A priority patent/MXPA06000228A/en
Publication of WO2005005398A2 publication Critical patent/WO2005005398A2/en
Publication of WO2005005398A3 publication Critical patent/WO2005005398A3/en
Priority to IS8178A priority patent/IS8178A/en
Priority to IL172785A priority patent/IL172785A0/en
Priority to NO20060558A priority patent/NO20060558L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

This invention relates to new oxazolidinones having a cyclopropyl moiety, which are effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci, Bacteroides spp., Clostridia spp. species, as well as acid-fast organisms such as Mycobacterium tuberculosis and other mycobactenial species. The compounds are represented by structural formula: (I): its enantiomer, diastereomer, or pharmaceutically acceptable salt or ester thereof.
PCT/US2004/020734 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof WO2005005398A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CA2530140A CA2530140C (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
DE602004027811T DE602004027811D1 (en) 2003-07-02 2004-06-29 CYCLOPROPYL GROUP SUBSTITUTED OXAZOLIDINONANTIBIOTICS AND DERIVATIVES THEREOF
CN200480019102.2A CN1816548B (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
AU2004256083A AU2004256083B2 (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
EP04777196A EP1646629B1 (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
AT04777196T ATE471937T1 (en) 2003-07-02 2004-06-29 CYCLOPROPYL GROUP SUBSTITUTED OXAZOLIDINONE ANTIBIOTICS AND DERIVATIVES THEREOF
BRPI0411688-7A BRPI0411688A (en) 2003-07-02 2004-06-29 cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
NZ544237A NZ544237A (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
JP2006517736A JP4607107B2 (en) 2003-07-02 2004-06-29 Cyclopropyl-substituted oxazolidinone antibiotics and their derivatives
MXPA06000228A MXPA06000228A (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof.
IS8178A IS8178A (en) 2003-07-02 2005-12-13 Oxazolidinone Fukuyl substituted with cyclopropyl group and their derivatives
IL172785A IL172785A0 (en) 2003-07-02 2005-12-22 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
NO20060558A NO20060558L (en) 2003-07-02 2006-02-02 Cyclopropyl group substituted oxazolidinone antibiotic agents and derivatives thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48390403P 2003-07-02 2003-07-02
US60/483,904 2003-07-02
US54698404P 2004-02-24 2004-02-24
US60/546,984 2004-02-24

Publications (2)

Publication Number Publication Date
WO2005005398A2 WO2005005398A2 (en) 2005-01-20
WO2005005398A3 true WO2005005398A3 (en) 2005-04-28

Family

ID=34068173

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/020734 WO2005005398A2 (en) 2003-07-02 2004-06-29 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof

Country Status (23)

Country Link
US (2) US7462633B2 (en)
EP (1) EP1646629B1 (en)
JP (1) JP4607107B2 (en)
KR (1) KR20060113625A (en)
AR (1) AR044990A1 (en)
AT (1) ATE471937T1 (en)
AU (1) AU2004256083B2 (en)
BR (1) BRPI0411688A (en)
CA (1) CA2530140C (en)
CL (1) CL2004001678A1 (en)
DE (1) DE602004027811D1 (en)
EC (1) ECSP056257A (en)
IL (1) IL172785A0 (en)
IS (1) IS8178A (en)
MA (1) MA27938A1 (en)
MX (1) MXPA06000228A (en)
MY (1) MY140137A (en)
NO (1) NO20060558L (en)
NZ (1) NZ544237A (en)
PE (1) PE20050732A1 (en)
RU (1) RU2348628C2 (en)
TW (1) TW200510421A (en)
WO (1) WO2005005398A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2794494C2 (en) * 2016-10-17 2023-04-19 МЕРК ШАРП И ДОУМ ЭлЭлСи Oxazolidinone compounds and methods of their application as antibacterial agents

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002360238B2 (en) * 2001-04-17 2007-11-15 Kyorin Pharmaceutical Co., Ltd. Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
WO2005019211A2 (en) * 2003-06-03 2005-03-03 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic compounds and methods of making and using the same
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1646629B1 (en) 2003-07-02 2010-06-23 Merck Sharp & Dohme Corp. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
US20070293493A1 (en) * 2003-07-02 2007-12-20 Milton Hammond Oxazolidinone antibiotics and derivatives thereof
US7129259B2 (en) * 2003-12-17 2006-10-31 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (en) 2003-12-18 2008-08-26 동아제약주식회사 Novel oxazolidinone derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same for antibiotics
EP1799677A1 (en) * 2004-10-08 2007-06-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
JP5534497B2 (en) 2005-06-08 2014-07-02 メリンタ セラピューティクス，インコーポレイテッド Method for synthesizing triazoles
US20090018123A1 (en) * 2005-06-20 2009-01-15 Milind D Sindkhedkar Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
AR054608A1 (en) * 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd OXAZOLIDINONE DERIVATIVES LINKED TO QUINOLONES AS ANTIBACTERIALS
AU2008260647A1 (en) * 2007-05-23 2008-12-11 Merck Sharp & Dohme Corp. Cyclopropyl pyrrolidine orexin receptor antagonists
US8604209B2 (en) 2008-10-10 2013-12-10 Trius Therapeutics, Inc. Methods for preparing oxazolidinones and compositions containing them
KR101739923B1 (en) 2009-02-03 2017-05-25 머크 샤프 앤드 돔 코포레이션 Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR20120106697A (en) 2009-06-26 2012-09-26 파나세아 바이오테크 리미티드 Novel azabicyclohexanes
BR112013007566A2 (en) 2010-09-28 2016-08-02 Panacea Biotec Ltd new bicyclic compounds
WO2017066964A1 (en) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352781A2 (en) * 1988-07-29 1990-01-31 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
WO1994013649A1 (en) * 1992-12-08 1994-06-23 The Upjohn Company Tropone-substituted phenyloxazolidinone antibacterial agents
US5736545A (en) * 1996-02-26 1998-04-07 Pharmacia & Upjohn Company Azolyl piperazinyl phenyl oxazolidinone antimicrobials
WO2001094342A1 (en) * 2000-06-05 2001-12-13 Dong A Pharm. Co., Ltd. Novel oxazolidinone derivatives and a process for the preparation thereof
WO2003027083A1 (en) * 2001-04-17 2003-04-03 Merck & Co., Inc. Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
WO2004048350A2 (en) * 2002-11-28 2004-06-10 Astrazeneca Ab Oxazolidinones as antibacterial agents
US20040147760A1 (en) * 2002-02-25 2004-07-29 Thomas Richard Charles N-aryl-2-oxazolidinone-5-carboxamides and their derivatives

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053593A (en) * 1975-11-26 1977-10-11 Lew Frumoff Medical product combining antimicrobial, antiporasitic and vitamin complex
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
TW286317B (en) 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (en) * 1994-07-20 1996-04-04 Bayer Ag 6-membered nitrogen-containing heteroaryl oxazolidinones
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
ATE204874T1 (en) 1995-05-11 2001-09-15 Upjohn Co SPIROCYCLIC AND BICYCLIC DIAZINYL AND CARBAZINYLOXAZOLIDINONES
WO2000070758A1 (en) 1999-05-14 2000-11-23 Kabushiki Kaisha Toshiba Surface acoustic wave device
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
JP2003522763A (en) 2000-02-10 2003-07-29 ファルマシア・アンド・アップジョン・カンパニー Oxazolidinone thioamide with piperazine amide substituent
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
BR0112826A (en) * 2000-07-17 2003-06-24 Ranbaxy Lab Ltd Oxazolidinone derivatives as antimicrobials
AU2001293163A1 (en) * 2000-09-27 2002-04-08 Lynx Therapeutics, Inc. Method for determining relative abundance of nucleic acid sequences
US6689769B2 (en) 2000-12-21 2004-02-10 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
YU52403A (en) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
EP1448536A1 (en) 2001-11-29 2004-08-25 Merck & Co., Inc. Cyclopropyl-containing oxazolidinone antibiotics and derivatives thereof
CN1155585C (en) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5-substituted oxazolidinone derivative and its preparing process and application
TW200302095A (en) 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AR038536A1 (en) 2002-02-25 2005-01-19 Upjohn Co N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES
US7473699B2 (en) 2002-02-28 2009-01-06 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents
BR0310074A (en) 2002-05-15 2005-03-08 Ranbaxy Lab Ltd Polymorphic forms of phenyl oxazolidinone derivatives
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
WO2004089943A1 (en) 2003-04-09 2004-10-21 Pharmacia & Upjohn Company Llc Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
EP1625124A1 (en) 2003-05-06 2006-02-15 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
EP1656357A1 (en) * 2003-07-02 2006-05-17 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
US20070293493A1 (en) * 2003-07-02 2007-12-20 Milton Hammond Oxazolidinone antibiotics and derivatives thereof
EP1646629B1 (en) * 2003-07-02 2010-06-23 Merck Sharp & Dohme Corp. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
JP2007521283A (en) * 2003-07-02 2007-08-02 メルク アンド カンパニー インコーポレーテッド Oxazolidinone antibiotics and derivatives thereof substituted with cyclopropyl groups

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352781A2 (en) * 1988-07-29 1990-01-31 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
WO1994013649A1 (en) * 1992-12-08 1994-06-23 The Upjohn Company Tropone-substituted phenyloxazolidinone antibacterial agents
US5523403A (en) * 1992-12-08 1996-06-04 The Upjohn Company Tropone-substituted phenyloxazolidinone antibacterial agents
US5736545A (en) * 1996-02-26 1998-04-07 Pharmacia & Upjohn Company Azolyl piperazinyl phenyl oxazolidinone antimicrobials
WO2001094342A1 (en) * 2000-06-05 2001-12-13 Dong A Pharm. Co., Ltd. Novel oxazolidinone derivatives and a process for the preparation thereof
WO2003027083A1 (en) * 2001-04-17 2003-04-03 Merck & Co., Inc. Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof
US20040147760A1 (en) * 2002-02-25 2004-07-29 Thomas Richard Charles N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2004048350A2 (en) * 2002-11-28 2004-06-10 Astrazeneca Ab Oxazolidinones as antibacterial agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2794494C2 (en) * 2016-10-17 2023-04-19 МЕРК ШАРП И ДОУМ ЭлЭлСи Oxazolidinone compounds and methods of their application as antibacterial agents

Also Published As

Publication number Publication date
AU2004256083A1 (en) 2005-01-20
JP2007521281A (en) 2007-08-02
MXPA06000228A (en) 2006-06-27
IL172785A0 (en) 2006-06-11
EP1646629B1 (en) 2010-06-23
IS8178A (en) 2005-12-13
JP4607107B2 (en) 2011-01-05
US7462633B2 (en) 2008-12-09
TW200510421A (en) 2005-03-16
US20070203187A1 (en) 2007-08-30
NO20060558L (en) 2006-02-02
CA2530140A1 (en) 2005-01-20
AR044990A1 (en) 2005-10-12
ATE471937T1 (en) 2010-07-15
CA2530140C (en) 2010-11-09
NZ544237A (en) 2008-09-26
DE602004027811D1 (en) 2010-08-05
AU2004256083B2 (en) 2007-10-11
PE20050732A1 (en) 2005-11-02
US7582659B2 (en) 2009-09-01
WO2005005398A2 (en) 2005-01-20
MY140137A (en) 2009-11-30
US20050038092A1 (en) 2005-02-17
CL2004001678A1 (en) 2005-05-20
RU2348628C2 (en) 2009-03-10
ECSP056257A (en) 2006-04-19
BRPI0411688A (en) 2006-12-26
EP1646629A2 (en) 2006-04-19
MA27938A1 (en) 2006-06-01
RU2005140379A (en) 2007-08-10
KR20060113625A (en) 2006-11-02

Similar Documents

Publication Publication Date Title
WO2005005398A3 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
ATE304536T1 (en) OXAZOLIDINONE ANTIBIOTICS CONTAINING BICYCLO(3,1,0)HEXANE AS A STRUCTURAL ELEMENT AND THEIR DERIVATIVES
MX9703543A (en) Bicyclic oxazine and thiazine oxazolidinone antibacterials.
LU92834I2 (en) TEDIZOLIDE, OPTIONALLY IN THE FORM OF AN ESTER, IN PARTICULAR A PHOSPHATE OR SALT THEREOF PHARMACEUTICALLY ACCEPTABLE
HK1083097A1 (en) Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
ES2162941T3 (en) ANTIMICROBIAL COMPOUNDS OF PHENYLOXAZOLIDINONE.
WO2006105127A8 (en) Hydroxysteroid dehydrogenase inhibitors
EP1409464A4 (en) Oxazolidinone derivatives as potential antimicrobials
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
WO2010058423A3 (en) Novel antimicrobials
MX9703040A (en) Phenyloxazolidinone antimicrobials.
UA88448C2 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
CA2386772A1 (en) Pentacyclic taxane compound
WO2006018682A3 (en) Oxazolidinone derivatives as antimicrobials
DOP2004000942A (en) ANTIBIOTICS OF OXAZOLIDINONA REPLACED WITH A CYCLOPROPILE GROUP AND DERIVATIVES OF THE SAME (CYCLOPROPYL GROUP SUBSTITUED OXAZOLDINONE ANTIBIOTICS AND DERIVATIVES THEREOF)
WO2009116090A3 (en) Novel antimicrobials

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480019102.2

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004256083

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 5837/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 544237

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2530140

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/000228

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2005/10432

Country of ref document: ZA

Ref document number: 172785

Country of ref document: IL

Ref document number: 200510432

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2006517736

Country of ref document: JP

Ref document number: 1200501911

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: DZP2004000504

Country of ref document: DZ

WWE Wipo information: entry into national phase

Ref document number: 05131137

Country of ref document: CO

WWE Wipo information: entry into national phase

Ref document number: 1020067000071

Country of ref document: KR

Ref document number: 12006500008

Country of ref document: PH

WWP Wipo information: published in national office

Ref document number: 2004256083

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2004777196

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2005140379

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2004777196

Country of ref document: EP

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWP Wipo information: published in national office

Ref document number: 1020067000071

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0411688

Country of ref document: BR